Trial NCT03509584

View at ClinicalTrials.gov 
Org. Study IDs: 2017-21
Secondary IDs: 2017-001198-18

Last trial update was posted on 2023-06-15

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

SAFETY

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID